This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Rep. Steve Cohen Discusses Marijuana Legal Reform

NEW YORK ( TheStreet) -- Rep. Steve Cohen (D-TN) has been one of the leading advocates of marijuana reform in Congress. He has urged U.S. Attorney General Eric Holder to remove marijuana from "Schedule 1" of the Controlled Substances Act. His tough questioning of Drug Enforcement Administration chief Michele Leonhart has been viewed on YouTube more than a quarter of a million times. Proposed legislation includes the "Unmuzzle the Drug Czar Act" which would repeal a little known provision of federal law that requires the director of the Office of National Drug Control Policy (ONDCP), informally known as the U.S. Drug Czar, to "take such actions as necessary to oppose any attempt to legalize the use" of marijuana or any Schedule I drug for medical or non-medical use. He spoke with TheStreet by telephone last week.

TheStreet: Rather than pushing for marijuana to be legal at the federal level, you believe each state should determine what it wants to do individually with regard to marijuana laws. Why is that?

Rep. Cohen: Well, because that's what we do with alcohol, and I don't know that the federal government has ever taken a position that it should-- except by Constitutional amendment, prohibit or allow any type of substance like that. I guess we do with drugs, we make certain drugs, FDA would have to approve them for use. But generally, the states make determinations on criminal laws, and...recreational drugs.

TheStreet: And what is your position, I mean, should a 20-year-old or 18-year-old or 16-year-old, for that matter, be able to walk into a store and buy marijuana?

1 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
AAPL $124.75 0.00%
FB $80.78 0.00%
GOOG $524.05 0.00%
TSLA $206.79 0.00%
YHOO $44.45 0.00%

Markets

DOW 17,826.30 -279.47 -1.54%
S&P 500 2,081.18 -23.81 -1.13%
NASDAQ 4,931.8150 -75.9760 -1.52%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs